ZA200104280B - Pharmaceutical combination preparations. - Google Patents
Pharmaceutical combination preparations.Info
- Publication number
- ZA200104280B ZA200104280B ZA200104280A ZA200104280A ZA200104280B ZA 200104280 B ZA200104280 B ZA 200104280B ZA 200104280 A ZA200104280 A ZA 200104280A ZA 200104280 A ZA200104280 A ZA 200104280A ZA 200104280 B ZA200104280 B ZA 200104280B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical combination
- combination preparations
- preparations
- pharmaceutical
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98122489 | 1998-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200104280B true ZA200104280B (en) | 2002-08-26 |
Family
ID=8233041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200104280A ZA200104280B (en) | 1998-11-27 | 2001-05-24 | Pharmaceutical combination preparations. |
Country Status (22)
Country | Link |
---|---|
US (3) | US6403579B1 (xx) |
EP (1) | EP1131072B1 (xx) |
JP (2) | JP2002531395A (xx) |
KR (1) | KR100421347B1 (xx) |
CN (1) | CN1184971C (xx) |
AR (1) | AR020287A1 (xx) |
AT (1) | ATE238056T1 (xx) |
AU (1) | AU765977B2 (xx) |
BR (1) | BR9915610A (xx) |
CA (1) | CA2352361C (xx) |
CO (1) | CO5011053A1 (xx) |
DE (1) | DE69907252T2 (xx) |
DK (1) | DK1131072T3 (xx) |
ES (1) | ES2195638T3 (xx) |
MY (1) | MY121831A (xx) |
PE (1) | PE20001302A1 (xx) |
PT (1) | PT1131072E (xx) |
TR (3) | TR200200982T2 (xx) |
TW (1) | TWI228414B (xx) |
UY (1) | UY25821A1 (xx) |
WO (1) | WO2000032174A2 (xx) |
ZA (1) | ZA200104280B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
WO2002065834A2 (en) * | 2000-10-24 | 2002-08-29 | Smithkline Beecham Corporation | Novel formulations of carvedilol |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
IN191028B (xx) * | 2001-05-17 | 2003-09-13 | Sun Pharmaceutical Ind Ltd | |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
WO2003092622A2 (en) * | 2002-04-30 | 2003-11-13 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
EP1539140A4 (en) | 2002-06-27 | 2005-12-07 | Sb Pharmco Inc | CARVEDILOLHYDOBROMID |
BR0312102A (pt) * | 2002-06-27 | 2007-05-29 | Sb Pharmco Inc | sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento |
EP1562552A1 (en) | 2002-11-08 | 2005-08-17 | Egalet A/S | Controlled release carvedilol compositions |
EP1610767B1 (en) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphine controlled release system |
WO2004094378A1 (en) * | 2003-04-21 | 2004-11-04 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
AU2003272851A1 (en) * | 2003-09-26 | 2005-04-14 | Shuyi Zhang | Sustained release preparation containing hydrochlorothiazide |
JP2007512372A (ja) | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | カルベジロール塩、対応する組成物、送達および/または治療方法 |
US20050169994A1 (en) * | 2003-11-25 | 2005-08-04 | Burke Matthew D. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
US8734850B2 (en) * | 2003-11-25 | 2014-05-27 | Flamel Technologies | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form |
CN1886132A (zh) * | 2003-12-02 | 2006-12-27 | 尼科克斯公司 | 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物 |
EP2281556A1 (en) * | 2005-02-25 | 2011-02-09 | F. Hoffmann-La Roche AG | Tablets with improved drugs substance dispersibility |
DE602007012692D1 (de) | 2006-06-16 | 2011-04-07 | Lek Pharmaceuticals | Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan |
GB0612540D0 (en) * | 2006-06-23 | 2006-08-02 | Novartis Ag | Galenical formulations of organic compounds |
WO2008114276A1 (en) * | 2007-03-16 | 2008-09-25 | Lupin Limited | Novel oral controlled release composition of carvedilol |
EP2155167A2 (en) | 2007-06-04 | 2010-02-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
US20130121916A1 (en) * | 2010-03-10 | 2013-05-16 | Sergio Baroni | Compositions for Colon Lavage and Methods of Making and Using Same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
PL169106B1 (pl) * | 1991-01-30 | 1996-06-28 | Wellcome Found | Sposób wytwarzania dyspergowalnej w wodzie tabletki PL PL PL PL PL PL PL |
DE69222006T2 (de) * | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
-
1999
- 1999-11-19 PE PE1999001171A patent/PE20001302A1/es not_active Application Discontinuation
- 1999-11-20 CA CA002352361A patent/CA2352361C/en not_active Expired - Lifetime
- 1999-11-20 ES ES99957320T patent/ES2195638T3/es not_active Expired - Lifetime
- 1999-11-20 BR BR9915610-5A patent/BR9915610A/pt not_active Application Discontinuation
- 1999-11-20 JP JP2000584870A patent/JP2002531395A/ja active Pending
- 1999-11-20 CN CNB998137561A patent/CN1184971C/zh not_active Expired - Lifetime
- 1999-11-20 AT AT99957320T patent/ATE238056T1/de active IP Right Maintenance
- 1999-11-20 PT PT99957320T patent/PT1131072E/pt unknown
- 1999-11-20 DK DK99957320T patent/DK1131072T3/da active
- 1999-11-20 WO PCT/EP1999/008972 patent/WO2000032174A2/en active IP Right Grant
- 1999-11-20 TR TR2002/00982T patent/TR200200982T2/xx unknown
- 1999-11-20 TR TR2001/01470T patent/TR200101470T2/xx unknown
- 1999-11-20 TR TR2002/00981T patent/TR200200981T2/xx unknown
- 1999-11-20 AU AU15065/00A patent/AU765977B2/en not_active Expired
- 1999-11-20 EP EP99957320A patent/EP1131072B1/en not_active Expired - Lifetime
- 1999-11-20 DE DE69907252T patent/DE69907252T2/de not_active Expired - Lifetime
- 1999-11-20 KR KR10-2001-7006570A patent/KR100421347B1/ko active IP Right Grant
- 1999-11-23 US US09/447,872 patent/US6403579B1/en not_active Expired - Lifetime
- 1999-11-24 AR ARP990105974A patent/AR020287A1/es unknown
- 1999-11-25 CO CO99074400A patent/CO5011053A1/es unknown
- 1999-11-25 MY MYPI99005155A patent/MY121831A/en unknown
- 1999-11-26 UY UY25821A patent/UY25821A1/es unknown
-
2000
- 2000-02-23 TW TW089103144A patent/TWI228414B/zh not_active IP Right Cessation
-
2001
- 2001-05-24 ZA ZA200104280A patent/ZA200104280B/xx unknown
- 2001-09-05 US US09/946,205 patent/US20020052367A1/en not_active Abandoned
-
2003
- 2003-10-24 US US10/693,243 patent/US20040087578A1/en not_active Abandoned
-
2006
- 2006-10-19 JP JP2006284476A patent/JP2007077160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1131072B1 (en) | 2003-04-23 |
CN1184971C (zh) | 2005-01-19 |
CN1328460A (zh) | 2001-12-26 |
AU1506500A (en) | 2000-06-19 |
TWI228414B (en) | 2005-03-01 |
KR20010080578A (ko) | 2001-08-22 |
US20020052367A1 (en) | 2002-05-02 |
MY121831A (en) | 2006-02-28 |
CO5011053A1 (es) | 2001-02-28 |
TR200200981T2 (tr) | 2002-06-21 |
US20040087578A1 (en) | 2004-05-06 |
CA2352361C (en) | 2007-01-02 |
KR100421347B1 (ko) | 2004-03-06 |
AU765977B2 (en) | 2003-10-09 |
DK1131072T3 (da) | 2003-08-11 |
DE69907252T2 (de) | 2004-01-29 |
ATE238056T1 (de) | 2003-05-15 |
CA2352361A1 (en) | 2000-06-08 |
JP2002531395A (ja) | 2002-09-24 |
TR200101470T2 (tr) | 2001-11-21 |
UY25821A1 (es) | 2001-07-31 |
BR9915610A (pt) | 2001-08-14 |
TR200200982T2 (tr) | 2002-06-21 |
PT1131072E (pt) | 2003-08-29 |
US6403579B1 (en) | 2002-06-11 |
AR020287A1 (es) | 2002-05-02 |
WO2000032174A2 (en) | 2000-06-08 |
WO2000032174A3 (en) | 2000-11-16 |
PE20001302A1 (es) | 2000-11-30 |
DE69907252D1 (de) | 2003-05-28 |
ES2195638T3 (es) | 2003-12-01 |
EP1131072A2 (en) | 2001-09-12 |
JP2007077160A (ja) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA993338B (en) | Pharmaceutical formulations. | |
ZA200104280B (en) | Pharmaceutical combination preparations. | |
CZ20011518A3 (cs) | Farmaceutický prostředek | |
ZA989061B (en) | Medicaments. | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
HK1027957A1 (en) | Pharmaceutical composition. | |
ZA981029B (en) | Pharmaceutical agents. | |
ZA9710071B (en) | Pharmaceutical composition. | |
ZA9710927B (en) | Pharmaceutical composition. | |
ZA974735B (en) | Pharmaceutical compositions. | |
HK1042245A1 (en) | Pharmaceutical moxifloxacin preparation. | |
HK1038884A1 (en) | Medicinal compositions. | |
ZA9811504B (en) | Novel pharmaceutical. | |
MXPA01012478A (es) | Formulaciones farmaceuticas mejoradas. | |
ZA200005510B (en) | Pharmaceutical composition. | |
ZA200203707B (en) | Pharmaceutical combinations. | |
ZA977104B (en) | Pharmaceutical compositions. | |
ZA989680B (en) | Pharmaceutical composition. | |
ZA9811506B (en) | Novel pharmaceutical. | |
EP1145714A4 (en) | DRUGS | |
ZA9811505B (en) | Novel pharmaceutical. | |
HK1022853A1 (en) | Pharmaceutical compositions. | |
HK1040488A1 (en) | Pharmaceutical formulations. | |
ZA987392B (en) | Pharmaceutical composition. | |
HK1044117A1 (en) | Pharmaceutical composition. |